Publication Name	World Journal of Gastroenterology
Manuscript ID	9791
Country	Japan

Received	2014-03-02 20:58
Peer-Review Started	2014-03-02 21:24
First Decision by Editorial Office Director
Return for Revision	2014-05-13 08:38
Revised	2014-05-21 00:00
Publication Fee Transferred
Second Decision by Editor	2014-06-17 09:18
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-06-17 09:53
Articles in Press	2014-06-17 10:13
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-24 18:54
Publish the Manuscript Online	2014-11-17 15:12

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors
Manuscript Source	Unsolicited Manuscript
All Author List	Yoshiaki Kawaguchi, Atsuko Maruno, Yohei Kawashima, Hiroyuki Ito, Masami Ogawa and Tetsuya Mine
Funding Agency and Grant Number
Corresponding Author	Yoshiaki Kawaguchi, MD, PhD, Department of Gastroenterology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan. y711kawa@is.icc.u-tokai.ac.jp
Key Words	Amenorrhea; Everolimus; Neuroendocrine tumor; Pancreas; Adverse event
Core Tip	This is the first case report of amenorrhea as a rare adverse event associated with everolimus treatment for pancreatic neuroendocrine tumor. As the younger women might be included in pancreatic neuroendocrine tumors patients, we should put this adverse event into consideration.
Publish Date	2014-11-17 15:12
Citation	Kawaguchi Y, Maruno A, Kawashima Y, Ito H, Ogawa M, Mine T. Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors. World J Gastroenterol 2014; 20(42): 15920-15924
URL	http://www.wjgnet.com/1007-9327/full/v20/i42/15920.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i42.15920

Full Article (PDF)	WJG-20-15920.pdf
Full Article (Word)	WJG-20-15920.doc
Manuscript File	9791-Review.docx
Answering Reviewers	9791-Answering reviewers.pdf
Copyright License Agreement	9791-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	9791-Language certificate.pdf
Peer-review Report	9791-Peer reviews.pdf
Scientific Misconduct Check	9791-CrossCheck.jpg
Scientific Editor Work List	9791-Scientific editor work list.pdf